Noncontact mapping-guided ablation of atrial flutter and enhanced-density mapping of the inferior vena caval-tricuspid annulus isthmus

Three-dimensional visualization of cardiac activation has become important in providing further insights into pathophysiological mechanisms of arrhythmias and to increase the efficacy of catheter ablation. The noncontact mapping enables a single beat analysis in a reconstructed geometry of the cardiac chamber. The aim of the study was to describe three-dimensional activation patterns and inferior vena caval-tricuspid annulus (IVC-TA) isthmus conduction characteristics in patients with atrial flutter and the noncontact guidance of the radiofrequency ablation of this arrhythmia. In 34 patients with atrial flutter, the noncontact probe was deployed in the RA. The global three-dimensional activation and the isthmus conduction (enhanced density mapping) were delineated during ongoing a trial flutter and paced rhythms. Ablation was performed nonfluoroscopically based on reconstructed anatomy and conduction patterns. Noncontact mapping was compared and validated with conventional multielectrode technique. IVC-TA isthmus ablation was completed successfully in 33 (97%) of 34 patients. In one patient a lower loop reentry around the inferior vena cava was depicted as a mechanism of atrial flutter. In another patient with positive flutter waves in inferior leads, an activation pattern typical of counterclockwise flutter was demonstrated in propagation maps. During a follow-up of 15.9 +/- 5.9 months, two atrial flutter recurrences occurred (5.8%). A gap of the resumed conduction through the IVC-TA isthmus was delineated as a mechanism of recurrence and ablated with one and three radiofrequency applications. Noncontact mapping allows construction of the global activation patterns in typical and atypical atrial flutter. It enables the nonfluoroscopic guidance of atrial flutter ablation and a comprehensive evaluation of the ablation results.     

Clinical relevance and management of early recurrences after catheter ablation of atrial fibrillation

Evaluation of: Malasana G, Day JD, Weiss JP et al. A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation. J. Cardiovasc. Electrophysiol. DOI: 10.1111/j.1540–8167.2010.02005.x (2011) (Epub ahead of print).

Early recurrences of atrial arrhythmias are frequent and have been reported in up to 50% of patients after radiofrequency catheter ablation. As these arrhythmias do not definitively indicate therapy failure over the long term, this period is also referred to as the ‘blanking’ or ‘therapy stabilization’ period. Nevertheless, early recurrences have been linked to the occurrence of late recurrences after catheter ablation of atrial fibrillation. Treatment strategies aiming at these early recurrences range from conservative management to repeat catheter ablation with controversial results. In this article, we evaluate a recent publication investigating the efficacy of an aggressive rhythm control approach, with the use of prompt electrical cardioversion for early arrhythmia recurrences on long-term outcomes after atrial fibrillation ablation, and discuss the results in the light of current evidence.     

Radiofrequency ablation of cardiac arrhythmias using a three-dimensional real-time position management and mapping system

A recently developed three-dimensional real-time position management system (RPM) uses an ultrasound ranging technique that enables multiple distance measurements between two reference catheters and a mapping catheter each equipped with ultrasound transducers. In addition to three-dimensional representation of the catheters and ablation sites it displays real-time movements of catheters (including the tip and shaft). A recently released version of the system enables additional geometry reconstruction of the heart chamber and activation mapping. This study included 21 patients (mean age 59 +/- 14.5 years) referred for radiofrequency catheter ablation of various arrhythmias. Geometry was reconstructed by tracing the endocardial contour of the respective heart chambers. Global and local color coded activation maps were constructed to confirm the nature of arrhythmia and to guide ablation. Spontaneous or induced arrhythmias were typical atrial flutter (n = 8), atypical atrial flutter (n = 3), atrioventricular nodal reentrant tachycardia (n = 3), atrial tachycardia (n = 2), atrial fibrillation (n = 2), ventricular tachycardia (n = 2), and Wolff-Parkinson-White syndrome (n = 1). Geometry reconstruction and mapping of arrhythmias were possible in 20 of 21 patients. RPM-guided radiofrequency ablation was successful in 19 (95%) of 20 patients. Due to difficulties in steering the RPM mapping/ablation catheter, in 6 (28%) successfully mapped patients, radiofrequency ablation was performed using another catheter. In one patient, the RPM-guided map was inconclusive and in another patient, ablation failed due to multiple reentrant circuits. No complications were observed. In conclusion, the new RPM system enables geometry reconstruction and three-dimensional positioning of the ablation catheters, reconstruction of the activation maps, marking of anatomic structures and reproducible tracking of multiple ablation sites. The system could be used to guide radiofrequency ablation of atrial and ventricular arrhythmias.     

Use of Adenosine to Identify Patients at Risk for Recurrence of Accessory Pathway Conduction After Initially Successful Radiofrequency Catheter Ablation

Objectives: The use of adenosine after radiofrequency catheter ablation of accessory pathways was prospectively studied to determine its utility for identifying patients at risk for recurrence of accessory pathway conduction and to guide therapy that might reduce late recurrence in this group. Background: Accessory pathway conduction recursin 5%–12% of patients following initially "successful" radiofrequency catheter ablation. Adenosine may facilitate conduction over accessory pathways that have been modified by radiofrequency delivery, thus identifying patients at risk for recurrence. Methods: Radiofrequency catheter ablation was performed in 109 patients. Prior to ablation, 12–18 mg of adenosine was administered. After ablation, when all evidence of accessory pathway conduction remained absent for at least 30 minutes, adenosine 12–18 mg was again administered. Results: Adenosine given prior to radiofrequency catheter ablation did not block accessory pathway conduction in any patient. Adenosine given after elimination of accessory pathway conduction induced complete atrioventricular and ventriculoatrial block in 95 patients; 11 (11.6%) subsequently had recurrence of accessory pathway function. Accessory pathway conduction was unmasked by adenosine in 12 patients (11.2%). After further deliveries of radiofrequency energy, 7 of these 12 patients subsequently demonstrated adenosine induced atrioventricular and ventriculoatrial block; 1 of these 7 patients experienced recurrence of accessory pathway conduction. The remaining 5 patients demonstrated persistent accessory pathway conduction only with adenosine; all experienced clinical recurrence of accessory pathway function. Conclusion: The use of adenosine after presumed successful radiofrequency catheter ablation may reveal persistent accessory pathway conduction. Elimination of this latent accessory pathway conduction reduces the risk for recurrence.     

Radiofrequency Ablation of Symptomatic but Benign Ventricular Arrhythmias

Two cases are presented where ablation of severely symptomatic ventricular arrhythmias not responding to medical therapy was accomplished with radiofrequency current application. After a routine programmed stimulation protocol, a quadripolar ablation catheter with a 4-mm tip was advanced percutaneously into the left ventricle in one case and into the right ventricle in the second case; and after precise pace mapping, the arrhythmogenic focus was successfully ablated using radiofrequency current. The postablation ambulatory recording revealed virtual eradication of ventricular ectopy in both cases. In conclusion, in severely symptomatic cases of "benign" ventricular arrhythmias, radiofrequency ablation offers an effective therapeutic alternative.     

Advanced endocardial mapping systems

The technique of endocardial mapping was developed by the advancement of radiofrequency catheter ablation techniques. Because the catheter ablation has been performed various complex arrhythmias, simple-catheter based mapping methods was limited and multiple electrodes catheter mapping and computed mapping system were developed. The basket catheter has 64-unipolar electrodes and can records endocardial potential during arrhythmia for a moment. The electro-anatomical mapping system, CARTO system, can records entire circuit of arrhythmia and point the critical area, but it will expend more time for mapping and can not indicate for unstable arrhythmias. The new mapping systems, include noncontact mapping system and LocaLisa system, will be able to use in the near future in Japan.     

Mapping and Isolation of the Pulmonary Veins Using the PVAC Catheter

Objectives: We aimed to investigate the feasibility, efficacy, and safety of the pulmonary vein ablation catheter (PVAC) catheter (a novel multielectrode catheter using duty‐cycled bipolar and unipolar radiofrequency energy, Medtronic, Minneapolis, MN, USA) to completely isolate the pulmonary veins (PVs). Methods: Twenty‐seven patients (60 ± 8 years) with paroxysmal atrial fibrillation (AF) underwent PV isolation with the PVAC catheter. PVAC was used for both mapping and isolation of the PVs (PVAC‐guided ablation). After PVAC ablation, presence/absence of PV potentials (PVP) was verified using a conventional circular mapping catheter. In case of residual PVP on the circular catheter, PVAC ablation was continued. Results: After PVAC‐guided ablation 99 of 106 PVs (93%) and 21 of 27 patients (78%) were proven to be isolated. Failure to isolate was due to a mapping failure in four right‐sided PVs and a true ablation failure in three right‐sided PVs. After continued PVAC ablation, 103 of 106 PVs (97%) and 25 of 27 patients (93%) were shown to be isolated. The total procedural time from femoral vein access to complete catheter withdrawal was 176 ± 25 minutes. The actual dwelling‐time of the PVAC within the left atrium was 102 ± 37 minutes. Esophageal T° rise to >38.5° occurred in nine of 19 monitored patients (47%). Conclusions: (1) PVAC‐guided ablation (i.e., mapping and ablation with a single catheter) results in isolation of all PVs in 73% of the patients. (2) An additional circular mapping catheter is required to increase complete isolation rate to 93% of the patients. (3) Given the esophageal T° rise in almost 50% of patients, safety precautions are needed. (PACE 2010; 33:168–178)     

Low exposure radiation with conventional guided radiofrequency catheter ablation in pregnant women

Cardiac arrhythmias in pregnant women are a common entity and often drug-refractory. The major concern about using radiofrequency (RF) catheter ablation guided by fluoroscopy to treat arrhythmias during pregnancy is the potential consequences of exposing the fetus to radiation. We present two pregnant patients with incessant and life-threatening supraventricular tachycardias successfully treated by conventional RF ablation under strict radioactive dosimeter surveillance. The availability of better fluoroscopy and lead shielding techniques allows to perform RF ablation of drug-refractory and poorly tolerated supraventricular arrhythmias at any stage of pregnancy, with an appropriate tracking of the radiation dose received by both mother and fetus.     

Clinical,electrophysiological and imaging predictors of atrial fibrillation ablation outcome

Introduction: Significant technological advances for catheter ablation of atrial fibrillation (AF) have occurred over the last decade, with a consequent increase in numbers of patients referred for AF ablation worldwide. Despite this, long-term success rates, particularly in those with persistent AF, remain modest. The patient population presenting for AF ablation are heterogeneous with regard to age, type of AF and presence of associated cardiovascular disease. Improved understanding of factors predicting response to AF ablation may therefore help to improve patient selection for ablation procedures.

Areas covered: This review outlines the clinical, electrophysiological and imaging predictors of response to radiofrequency ablation for AF in contemporary practice. Recently developed scoring systems incorporating these parameters are examined, as are factors identified thus far which may predict the outcome of cryoballoon ablation.

Expert commentary: Traditional clinical factors associated with ablation outcomes serve as surrogates rather than direct measures of the underlying arrhythmia substrate. An improved understanding of this substrate could improve the prediction of response to radiofrequency ablation. Continued development of methods for characterising the arrhythmia substrate, including atrial cardiac magnetic resonance imaging and invasive voltage mapping, may inform patient risk assessment and help guide selection for catheter ablation on an increasingly individualistic basis.     

Radiofrequency Catheter Ablation of Atriofascicular Accessory Pathways Guided by Discrete Electrical Potentials Recorded at the Tricuspid Annulus

Background: The purpose of this study was to test the feasibility of using the recording of discrete electrical potentials to guide radiofrequency catheter ablation of atriofascicular accessory pathways with Mahaim-like properties. Methods and Results: Four patients (3 females, 1 male) who fulfilled criteria for having atriofascicular accessory pathways with Mahaim-like properties and preexcited reciprocating tachycardia underwent radiofrequency catheter ablation. The mean age was 35 years (range 27–47). Symptoms were present for a mean of 10.5 years (range 6–18). Recording of discrete electrical potentials of the atriofascicular pathway was attempted by mapping the tricuspid annulus in sinus rhythm, during atrial pacing, and during reciprocating tachycardia. During atrial pacing, a mean of seven radiofrequency pulses (range 1–14), delivered to the tricuspid annulua at the area where electrical potentials were recorded, eliminated conduction through the atriofascicular accessory pathway in all patients. No complications occurred. Tachycardia did not reoccur during a mean follow-up of 5 months (range 3–9). Conclusions: Recording of discrete electrical potentials at the tricuspid annulus identifies an optimal ablation site where radiofrequency current can safely eliminate conduction through atriofascicular accessory pathways with Mahaim-like properties.     

Advances in Applications of Radiofrequency Current to Catheter Ablation Therapy

In the past 5 years, numerous reports have appeared of the use of radiofrequency (RF) current as an energy source for catheter ablation therapy of cardiac arrhythmias. Laboratory investigations using in vitro and in vivo animal models to study the biophysical and histologic effects as well as to assess the efficacy and safety of this technique in ablating various cardiac structures have been extensively performed and have led to successful applications in humans. Clinical experience with RF catheter ablation of the AV junction and accessory pathway has proliferated each year. However, experience with RF ablation of the VT focus remains quite limited. With further advances in catheter electrode design for mapping and ablation, a widespread application of RF catheter ablation to the treatment of cardiac arrhythmias is anticipated.     

Radiofrequency Catheter Ablation of Accessory Pathways During Entrainment of AV Reentrant Tachycardia

Radiofrequency ablation of accessory pathways must sometimes be done during orthodromic atrioventricular reentrant tachycardia when manifest anterograde accessory pathway conduction is absent or retrograde fusion obscures accessory pathway location during ventricular pacing. Unfortunately, abrupt heart rate slowing upon radiofrequency induced termination of atrioventricular reentrant tachycardia often causes catheter dislodgment. We report our experience in circumventing this problem during radiofrequency ablation by using entrainment of atrioventricular reentrant tachycardia. The latter maintains retrograde activation pattern over the accessory pathway while preventing abrupt ventricular rate change. Eight patients (4 men and 4 women, mean age 37.3 ± 17.9) with eleven left-sided accessory pathways were included. Ablation during entrainment was used as the first approach in three patients with concealed accessory pathways and one patient with a bidirectional accessory pathway. In another four patients, ablation during entrainment was used after technical difficulties in ablating during tachycardia. Only 1–3 radiofrequency applications were required to eliminate the accessory pathway using the entrainment technique. The catheter remained stable when accessory pathway conduction was interrupted by radiofrequency current. In conclusion, entrainment of atrioventricular reentrant tachycardia during radiofrequency application is useful for maintaining catheter position for accessory pathway ablation during atrioventricular reentrant tachycardia.     

Remote magnetic versus manual catheter navigation for ablation of supraventricular tachycardias: a randomized, multicenter trial

Introduction: The potential benefits of remote robotic navigation for catheter ablation procedures have not been demonstrated in controlled clinical trials. The purpose of this study was to compare remote magnetic catheter navigation to manual navigation for the ablation of common supraventricular arrhythmias. Methods and Results: Patients with supraventricular arrhythmias due to atrioventricular (AV) nodal reentry, accessory pathways, or undergoing AV junctional ablation for complete heart block were randomized in a 3:1 ratio between magnetic (Niobe system and Helios II catheter, Stereotaxis, Inc., St. Louis, MO) and manual navigation for radiofrequency ablation at 13 centers. The primary endpoint of the study was total fluoroscopic time. Fifty‐six patients were randomized to magnetic navigation and 15 to manual navigation. AV nodal reentry was the most common arrhythmia in both groups. Total fluoroscopy time was reduced in the magnetic navigation group (median 17.8 minutes, interquartile (IQ) range 9.9,27.8 minutes) compared to manual navigation (27.1, IQ 19.0,48.0, P < 0.05). The acute success rates (91% for magnetic and 87% for manual navigation, P > 0.05) did not differ between groups. The number of lesions delivered was less for magnetic navigation (6, IQ 4,9 vs 10, IQ 7, 26, P < 0.05). Total procedure time (median 151, IQ 111, 221 minutes magnetic and 151, IQ 110, 221 minutes manual) and complication rates (5.4% patients magnetic and 6.7% patients manual) were similar between the groups (both P > 0.05). Conclusions: Remote magnetic catheter navigation reduces fluoroscopic time and radiofrequency lesion deliveries for the ablation of common supraventricular arrhythmias compared to manual catheter navigation.     

Imaging techniques in cardiac electrophysiology

Modern cardiac electrophysiology procedures include catheter-based arrhythmia ablation and transvenous device implantation, which are highly dependent on accurate, real-time cardiac imaging. With the realization that anatomic structures are critical to successful electrophysiologic procedures, accurately defining a patient's cardiac anatomy has become more important. Fluoroscopy allows for 2D imaging of cardiac structures in real-time, and is used to guide catheter and lead placement, but does not allow for visualization of soft tissues. Intracardiac echocardiography allows for both direct visualization of anatomic structures within the heart and real-time imaging during catheter placement. Despite advances in intracardiac echocardiography catheters that allow for larger windows, the ability to accurately delineate anatomic structures depends on the patient's anatomy and operator experience. Neither of these techniques allows for electrical mapping of the heart; however, both anatomic and electrical intracardiac mapping can be achieved with advanced mapping systems. These systems allow for real-time catheter localization, help elucidate cardiac anatomy, evaluate electrical activation during arrhythmias and guide catheter placement for deliverance of radiofrequency current. More recently, 3D cardiac computed tomography has been used to accurately define intracardiac anatomy; however, catheter tracking and electrical mapping cannot be performed by computed tomography. Mapping systems are now being merged with computed tomography images to produce an accurate anatomic and electrical map of the heart to guide catheter ablations. The objective of this paper is to describe the current imaging and mapping techniques used in electrophysiologic procedures.     

Radiofrequency Catheter Ablation: The Effect of Electrode Size on Lesion Volume In Vivo

Radiofrequency current is a promising alternative to high voltage direct current defibrillator discharges for catheter ablation of arrhythmias. However, lesions produced with radiofrequency current are relatively small and use of high power is limited by the impedance rise that occurs with desiccation of tissue and coagulum formation. The effect of electrode size on radiofrequency ablation was assessed by comparing results of radiofrequency application using a standard 6 French electrode catheter (distal electrode 2 mm in length) to those using catheters modified with longer distal electrodes (3, 4, 6, 8, and 10 mm in length). Radiofrequency ablation was performed at 47 left ventricular endocardial sites in 20 anesthetized dogs. A constant power of 13.3 +/- 1.3 watts at 550 kHz was applied between the distal catheter electrode and a skin electrode until a total of 500 joules had been delivered or a rise in impedance occurred. Increasing electrode length from 2 to 4 mm more than doubled lesion volume from a mean of 143 to 326 mm3 (P = 0.025). Increasing electrode length beyond 4 mm produced progressively smaller lesions (157 mm3, 155 mm3, and 67 mm3 for 6-, 8-, and 10-mm electrode lengths, respectively). Impedance rise was significantly less likely with larger electrodes and took longer to occur. Increasing the size of electrodes used for radiofrequency ablation allows application of higher power without an impedance rise. Optimizing electrode size (3 or 4 mm in this study) results in larger lesions and may improve the effectiveness of radiofrequency ablation of arrhythmias.     

新型腔内射频消融导管消融离体猪肝

目的 观察新型腔内射频消融导管对离体猪肝(肝实质、栓子模型)的消融效果。方法 应用EMcision Habib腔内射频消融导管及RITA射频发生器对新鲜离体猪肝肝实质及栓子模型进行消融,输出功率分别为5 W、10 W、15 W和20 W,消融时间分别为60 s、90 s和120 s,观察消融灶组织凝固形态及范围。结果 消融肝实质时,输出功率为10 W、延长消融时间(90 s延长至120 s),输出功率为15 W、延长消融时间(60 s延长至90 s)以及消融时间为60 s和90 s、增加输出功率(15 W增加至20 W)获得的消融灶长径增加(P均<0.05),而宽径增加不明显(P均>0.05)。消融栓子模型时,输出功率为10 W、延长消融时间(90 s延长至120 s),以及消融时间为60 s、增加输出功率(15 W增加至20 W)均可增加消融灶长径(P均<0.05),而宽径增加不明显(P均>0.05)。肉眼见所有消融灶附着处血管管壁颜色均与邻近血管管壁无差异。结论 采用EMcision Habib腔内射频导管消融离体猪肝可出现明确的消融范围,且对管道壁无明显损伤。     

Epicardial confirmation of conduction block during thoracoscopic surgery for atrial fibrillation - a hybrid surgical-electrophysiological approach

Abstract

Background: Totally thoracoscopic epicardial pulmonary vein ablation is an emerging treatment of atrial fibrillation (AF). A hybrid surgical-electrophysiological procedure with periprocedural confirmation of conduction block might reduce recurrences of AF or atrial tachycardia and improve surgical success. Methods and results: We report our joint surgical-electrophysiological approach for confirmation of conduction block across pulmonary vein ablation lines and those compartmentalizing the left atrium during totally thoracoscopic surgery. A diagnostic electrophysiology (EP) catheter positioned under the left atrium is used as reference and a custom-made multi-electrode for recording. Determination of conduction block across the pulmonary vein (PV) ablation lines requires measurement of activation time differences of milliseconds. Second, a stable reference electrogram to which to relate local activation time is required. Third, the recording electrode terminals and the inter-electrode distance should be small to prevent recording of far field activity and to allow recording of very small electrograms. We confirm entry and exit block and determine conduction block across linear ablation lines with differential pacing. Conclusion: A joint surgical-electrophysiological protocol for confirmation of conduction block across PV isolation lines and left atrial ablation lines is feasible and might prevent recurrences and further improve the success of minimally invasive surgery for AF.     

Imaging techniques in cardiac electrophysiology

Modern cardiac electrophysiology procedures include catheter-based arrhythmia ablation and transvenous device implantation, which are highly dependent on accurate, real-time cardiac imaging. With the realization that anatomic structures are critical to successful electrophysiologic procedures, accurately defining a patient’s cardiac anatomy has become more important. Fluoroscopy allows for 2D imaging of cardiac structures in real-time, and is used to guide catheter and lead placement, but does not allow for visualization of soft tissues. Intracardiac echocardiography allows for both direct visualization of anatomic structures within the heart and real-time imaging during catheter placement. Despite advances in intracardiac echocardiography catheters that allow for larger windows, the ability to accurately delineate anatomic structures depends on the patient’s anatomy and operator experience. Neither of these techniques allows for electrical mapping of the heart; however, both anatomic and electrical intracardiac mapping can be achieved with advanced mapping systems. These systems allow for real-time catheter localization, help elucidate cardiac anatomy, evaluate electrical activation during arrhythmias and guide catheter placement for deliverance of radiofrequency current. More recently, 3D cardiac computed tomography has been used to accurately define intracardiac anatomy; however, catheter tracking and electrical mapping cannot be performed by computed tomography. Mapping systems are now being merged with computed tomography images to produce an accurate anatomic and electrical map of the heart to guide catheter ablations. The objective of this paper is to describe the current imaging and mapping techniques used in electrophysiologic procedures.     

Catheter Interruption of Atrioventricular Conduction Using Radiofrequency Energy in a Patient with Transposition of the Great Arteries

Percutaneous catheter mapping andradiofrequency ablation of the AV node-His bundle system (with subsequent transvenous endocardial ventricular pacing) were performed on an 18-year-old woman with transposition of the great arteries and intact ventricular septum and chronic arrhythmias 15 years following a Mustard operation. Exclusion of the AV conduction tissue from the systemic venous circulation by the complex anatomy and the Mustard repair was circumvented by a retrograde approach across the aortic valve to the morphological right ventricle yielding access to the AV node-His bundle system.     

Clinical, Electrophysiological Characteristics, and Radiofrequency Catheter Ablation of Atrial Tachycardia Near the Apex of Koch's Triangle

Atrial tachycardia, with its focus near the apex of Koch's triangle, may carry a potential risk of atrioventricular block during radiofrequency catheter ablation. The efficacy and safety of this procedure have never been addressed. The characteristics and catheter ablation results are reported for six patients with atrial tachycardia near the apex of Koch's triangle. All six patients were female aged 49.6 ± 9.3 years (range 39–63). Organic heart disease was present in 3 (50%) of the 6 patients. The P wave in surface ECG had a mean axis of − 28° (range − 90°–+ 30°) in the frontal plane. The catheter ablation was guided by activation sequence mapping. The energy was titrated from low power level. Atrial overdrive pacing was used to monitor the atrioventricular conduction should accelerated functional rhythm occur. At the final successful ablation site, the local atrial activation was 41.8 ± 9.1 ms before the P wave and His-bundle potential was present in 5 of the 6 patients. All patients had their atrial tachycardia eliminated without recurrence or heart block during a follow-up period of 17.7 ± 8.5 months (range 6–30). In conclusion, atrial tachycardia near the apex of Koch's triangle has distinct clinical and electrophysiological features, Radiofrequency catheter ablation can be performed effectively. However, extreme care must be taken to prevent inadvertent atrioventricular block. Titrated energy application and continuous monitoring of atrioventricular conduction are mandatory.